{"product_id":"conmed-bcg-matrix","title":"Conmed Boston Consulting Group Matrix","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eActionable Strategy Starts Here\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eWant clarity on Conmed’s portfolio? This Conmed BCG Matrix preview shows which products lead, which generate steady cash, and which drag resources—now see the full picture. Purchase the complete BCG Matrix for quadrant-by-quadrant placements, data-backed recommendations, and a ready-to-use Word + Excel package that lets you act fast. Skip guesswork and get a strategic roadmap you can present to stakeholders today.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003etars\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAirSeal insufflation \u0026amp; smoke management\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAirSeal insufflation \u0026amp; smoke management holds a leading position in Conmed’s MIS portfolio, benefiting from rapid laparoscopy adoption and the clinical need for stable pneumoperitoneum. Maintaining OR mindshare requires ongoing investment in clinical education and expanded global placements. The platform is cash-intensive today but scale and installed-base momentum can convert it into a future cash cow. Continue funding evidence generation, KOL engagement, and multi-port deployments.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSports medicine arthroscopy portfolio\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSports medicine arthroscopy is a Star in Conmed's BCG matrix: anchors share in shoulder, knee and hip—implants, resections and disposables—benefit from ~10% procedure growth (2024). Leadership plus cross-selling drives utilization but needs ongoing promotion and surgeon-training budgets. Growth consumes cash via cadaver labs, reps and inventory, yet payoff is durable. Hold share and it matures into a high-yield engine.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAdvanced energy \u0026amp; electrosurgery in MIS\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAdvanced energy and electrosurgery are core to the OR as cases shift toward minimally invasive surgery, a market driving CONMED’s FY2024 revenue (~$1.23B) and sector growth above mid-single digits. Strong brand equity supports share, but intense competition requires sustained evidence generation and account conversion spend. High growth keeps working capital and field support elevated; protecting this edge compounds into a larger profit pool.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLaparoscopic access \u0026amp; disposable trocars\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eLaparoscopic access and disposable trocars sit as Stars: high-throughput, sticky consumables tied to rising MIS procedures (≈5% annual growth through 2024), solid share for Conmed but constant price pressure and competition force product refresh and contracting work. Volume drives cash-in while inventory and field support push cash-out; aggressive bundling and system placement are needed to lock long-term use and ride the MIS wave.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eHigh throughput; recurring consumables\u003c\/li\u003e\n\u003cli\u003e≈5% MIS procedural CAGR to 2024\u003c\/li\u003e\n\u003cli\u003ePrice pressure → frequent refresh\u003c\/li\u003e\n\u003cli\u003eBundle to protect share and margins\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInternational MIS expansion\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eInternational MIS expansion is a Star for ConMed as APAC\/EMEA adoption remains strong, with ConMed reporting expanded footing across core markets in 2024 and procedure volumes accelerating versus 2021‑23 levels. Current cash outflows for distribution build‑out, regulatory registrations and surgeon training depress margins today, but scale should drive contribution margin materially higher as share converts to recurring annuity revenue. Keep planting flags now to harvest steady aftermarket and consumable revenue later.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e2024: footprint expanded across multiple APAC\/EMEA markets\u003c\/li\u003e\n\u003cli\u003eNear term: heavy capex\/SG\u0026amp;A for registrations \u0026amp; training\u003c\/li\u003e\n\u003cli\u003eLong term: higher contribution margins, annuity-like consumables\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eFive surgical stars push FY24 momentum — revenue ≈ \u003cstrong\u003e$1.23B\u003c\/strong\u003e, reinvest to build annuity margins\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eConMed Stars (AirSeal, sports arthroscopy, advanced energy, trocars, international MIS) drive FY2024 momentum—company revenue ≈$1.23B—with segment growth rates ~5–10% and high consumable attach; heavy near‑term cash burn for reps, training and inventory but clear path to annuity margins; prioritize evidence, KOLs, bundling and system placements to convert scale into durable cash flow.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eStar\u003c\/th\u003e\n\u003cth\u003e2024 KPI\u003c\/th\u003e\n\u003cth\u003eCash\u003c\/th\u003e\n\u003cth\u003ePriority\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eAirSeal\u003c\/td\u003e\n\u003ctd\u003eHigh growth, OR share\u003c\/td\u003e\n\u003ctd\u003eNegative (scale)\u003c\/td\u003e\n\u003ctd\u003eEvidence\/KOLs\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eArthroscopy\u003c\/td\u003e\n\u003ctd\u003e~10% procedure growth\u003c\/td\u003e\n\u003ctd\u003eReinvestment\u003c\/td\u003e\n\u003ctd\u003eTraining\/cross‑sell\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAdvanced energy\u003c\/td\u003e\n\u003ctd\u003eMid‑SSD growth\u003c\/td\u003e\n\u003ctd\u003eSupport spend\u003c\/td\u003e\n\u003ctd\u003eAccount conversion\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTrocars\u003c\/td\u003e\n\u003ctd\u003e≈5% MIS CAGR\u003c\/td\u003e\n\u003ctd\u003eInventory heavy\u003c\/td\u003e\n\u003ctd\u003eBundling\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIntl MIS\u003c\/td\u003e\n\u003ctd\u003eExpanded APAC\/EMEA footprint\u003c\/td\u003e\n\u003ctd\u003eCapex\/SG\u0026amp;A\u003c\/td\u003e\n\u003ctd\u003eRegistrations\/training\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eConcise BCG analysis of Conmed products: Stars, Cash Cows, Question Marks, Dogs with investment and divest guidance.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eOne-page Conmed BCG snapshot pinpoints growth vs decline fast, easing strategic decisions and investor decks.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eash Cows\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eElectrosurgical generators \u0026amp; core RF accessories\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eElectrosurgical generators and core RF accessories are mature assets with a widely installed base and recurring disposable sales that drive predictable reorder patterns and stable margins; the global electrosurgery market was about USD 6.5 billion in 2024, reinforcing steady demand. Minimal promotion beyond refresh cycles and service keeps CAC low while service contracts preserve uptime. This segment reliably throws off cash, making it a classic milk-for-cash business for CONMED.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eVisualization towers, light sources, and scopes\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eVisualization towers, light sources, and scopes sit in Conmeds cash-cow quadrant with a large installed base driving recurring revenue in a slower-growth replacement market (global endoscopy equipment replacement ~2% CAGR). Service contracts and upgrade kits lift margins—Conmed reported FY2024 revenue of about $1.23 billion with service mix boosting gross margins. Selective hospital capex sustains baseline demand; prioritize service optimization, COGS reduction, and let the installed base fund growth bets.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eReusable laparoscopic instruments \u0026amp; trays\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eReusable laparoscopic instruments \u0026amp; trays are trusted workhorses in Conmed’s mature accounts, delivering steady procedure volume and contributing to FY2024 revenue of about $1.2B. Low growth but high utilization and efficient manufacturing allow gross margins above portfolio averages, making them profitable. Minimal marketing lift needed; they serve as margin-stacking items in contracts and provide dependable cash flow.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGeneral surgery disposables (tips, electrodes, accessories)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eGeneral surgery disposables (tips, electrodes, accessories) sit as cash cows for Conmed: high-volume, routine SKUs with defendable OR share; price-sensitive yet predictable demand drives scale efficiencies and steady margins. Promotion-light and operations-heavy, focus is on squeezing waste, protecting formulary positions, and harvesting cash for R\u0026amp;D and strategic bets.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eHigh-volume, routine SKUs\u003c\/li\u003e\n\u003cli\u003eDefendable OR\/formulary share\u003c\/li\u003e\n\u003cli\u003ePrice-sensitive; predictable demand\u003c\/li\u003e\n\u003cli\u003eLow promo, high ops focus\u003c\/li\u003e\n\u003cli\u003eSqueeze waste; harvest cash\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eService, training, and maintenance contracts\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eService, training, and maintenance contracts deliver recurring, sticky revenue with strong gross margins—Conmed reported services-led revenue of about $210 million in fiscal 2024, driving margins above corporate average. Renewal cycles are reliable and need modest selling effort, supporting customer loyalty without heavy capital intensity. Cash generated should be banked and selectively reinvested into growth franchises.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eRecurring revenue: ~$210M (2024)\u003c\/li\u003e\n\u003cli\u003eHigh gross margin: \u0026gt;company avg\u003c\/li\u003e\n\u003cli\u003eLow CAPEX, high retention\u003c\/li\u003e\n\u003cli\u003eReinvest selectively\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eElectrosurgery cash engines: disposables, services and reusable tools fueling growth\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eConmed cash cows—electrosurgical generators, visualization systems, reusable laparoscopic instruments, disposables and services—generate steady, high-margin cash from large installed bases and predictable replacement cycles. Global electrosurgery market ~$6.5B (2024) supports recurring disposables; Conmed FY2024 services ~$210M. Focus on margin improvement, COGS, service renewals and harvesting cash for growth.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eSegment\u003c\/th\u003e\n\u003cth\u003e2024 size\/rev\u003c\/th\u003e\n\u003cth\u003eNotes\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eElectrosurgery\u003c\/td\u003e\n\u003ctd\u003eMarket ~$6.5B\u003c\/td\u003e\n\u003ctd\u003eInstalled base, recurring disposables\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eVisualization\u003c\/td\u003e\n\u003ctd\u003eConmed ~$1.23B*\u003c\/td\u003e\n\u003ctd\u003eReplacement ~2% CAGR, service upsell\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eReusable laparoscopes\u003c\/td\u003e\n\u003ctd\u003eConmed ~$1.2B*\u003c\/td\u003e\n\u003ctd\u003eHigh utilization, low growth\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDisposables\u003c\/td\u003e\n\u003ctd\u003eHigh-volume\u003c\/td\u003e\n\u003ctd\u003eScale, price-sensitive\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eServices\u003c\/td\u003e\n\u003ctd\u003e~$210M\u003c\/td\u003e\n\u003ctd\u003eHigh margins, recurring\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eFull Transparency, Always\u003c\/span\u003e\u003cbr\u003eConmed BCG Matrix\u003c\/h2\u003e\n\u003cp\u003eThe file you're previewing is the exact Conmed BCG Matrix you'll receive after purchase. No watermarks, no sample pages—just a fully formatted, analysis-ready report built for clarity. Delivered as a ready-to-use file you can edit, print, or present immediately. One purchase, immediate access, no surprises.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"PortersFiveForce","offers":[{"title":"Default Title","offer_id":55674717831545,"sku":"conmed-bcg-matrix","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0914\/5276\/8633\/files\/conmed-bcg-matrix.png?v=1755793917","url":"https:\/\/portersfiveforce.com\/products\/conmed-bcg-matrix","provider":"Porter's Five Forces","version":"1.0","type":"link"}